Numerous Protein Therapeutics Products in Advanced Phase of Clinical Trials
There are a plethora of protein therapeutic products under the Phase III clinical trial development stage. The successful clinical trials of these products can revolutionize their usage and clinical applications. The most promising pipeline is for the monoclonal antibody products owing to the efficacy and specificity that they offer. These monoclonal antibodies are being researched for several disease applications. Primarily monoclonal antibodies are growing in the field of cancer due to their tumor specific targeting ability. Insulin products from Eli...
View full press release